Cite
Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection
MLA
Maria Rosario Barrena Caballo, et al. “Guillain-Barré Syndrome Associated with Leptomeningeal Enhancement Following SARS-CoV-2 Infection.” Clinical Medicine (London, England), vol. 20, no. 4, June 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b74316fca4b701ed9444e743aff55f20&authtype=sso&custid=ns315887.
APA
Maria Rosario Barrena Caballo, David Rivero Celada, Agustín Sancho-Saldaña, Marta Serrano-Ponz, Álvaro Lambea-Gil, Maria Haddad Garay, & Jose Luis Capablo Liesa. (2020). Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection. Clinical Medicine (London, England), 20(4).
Chicago
Maria Rosario Barrena Caballo, David Rivero Celada, Agustín Sancho-Saldaña, Marta Serrano-Ponz, Álvaro Lambea-Gil, Maria Haddad Garay, and Jose Luis Capablo Liesa. 2020. “Guillain-Barré Syndrome Associated with Leptomeningeal Enhancement Following SARS-CoV-2 Infection.” Clinical Medicine (London, England) 20 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b74316fca4b701ed9444e743aff55f20&authtype=sso&custid=ns315887.